It was found that pipemidic acid and related compounds have the common property of inhibiting the conjugal transfer of R plasmids carried by Escherichia coli and Pseudomonas aeruginosa. This inhibition was not due to bactericidal activity of the compounds against donors, recipients, or R+ transconjugants. However, it was correlated inversely with their minimal inhibitory concentrations, depending especially upon sensitivity of donors to the compounds. The inhibition was generally observed in mating systems using various combinations of 14 R plasmids and 9 bacterial strains. The pretreatment of a donor or a recipient strain with pipemidic acid showed only a small inhibitory effect on the transfer of an R plasmid, whereas the presence of the compound during an active mating caused a marked inhibitory effect.
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R-mediated drug resistance in bacteria is a serious problem in clinical medicine. In studies thus far made for anti-R plasmid agents, nalidixic acid was found to inhibit the conjugal transfer of R plasmids (10) . Pipemidic acid, a new synthetic antibacterial agent active against gram-negative bacteria includingPseudomonas aeruginosa (14) , is structurally related to nalidixic acid and shows a marked inhibition of the conjugal transfer of Rloo-l between strains of Escherichia coli. This finding raised the questions of whether such inhibition is a common property of this group of compounds and whether it is generally observed in various systems of R plasmid transfer. The present study was carried out to clarify these points.
MATERIALS AND METHODS R plasmids and bacterial strains. The R plasmids and bacterial strains used in this study are listed in Tables 1 and 2 , respectively. Pipemidic acid-resistant strains were made in vitro by 10 serial passages in nutrient broth containing the agent. These were all prepared in the Research Laboratories of Dainippon Pharmaceutical Co., Ltd., according to procedures described previously (6) (7) (8) (9) ; Japanese Patent Publ. 48-37279; Japanese Patent Application Disclosures 49-82670 and 49-126697). Appropriate amounts of 0.1 N sodium hydroxide were added to them when dissolved. Chloramphenicol was purchased from Sankyo Co., Ltd., and tetracycline hydrochloride was purchased from Takeda Chemical Industries, Ltd.
Media. Nutrient broth and SS agar were purchased from Eiken Co., Ltd. ALGa, AGGa, and AMGa broths or agars consisted of medium A (2), 0.5% L-glutamic acid, and 1% lactose, glucose, and maltose, respectively. Appropriate nutrients were added, if necessary, at a concentration of 30 ug/ml unless otherwise described.
Kinetics of R plasmid transfer. In the R plasmid transfer between strains of E. coli, donor (W4861 R,,,, ,+ or R,0+) and recipient (58-161) cells grown exponentially in nutrient broth (about 7 x 108 cells/ ml each) were mixed at a volume ratio of 1:9 and incubated at 37°C under static conditions. At various times after incubation, a 0.5-ml sample was taken, diluted 100 times with ice-chilled ALGa broth containing L-methionine (10 Ag/ml), and divided into two aliquots; one was treated with a blender (Nippon Seiki Co.) at 15,000 rpm for 30 s, and the other was left untreated. Both aliquots were incubated at 37°C for 10 min and diluted appropriately with the same broth. A 1.5-ml amount of each dilution was mixed with an equal volume of ALGa agar plus L-methionine (10 ,ug/ml) and chloramphenicol (50 ,ug/ml) and overlaid on the same agar containing chloramphenicol (25 ,ug/ml). After incubation at 37°C for 48 h, the colonies of R+ transconJugants were counted.
In the R plasnid transfer between strains of P. (ML4600) cells exponentially grown in nutrient broth containing 0.4% KNO3 (about 4 x 108 cells/ml each) were mated in the same manner as E. coli. Samples taken were diluted with AGGa broth containing L-tryptophan and L-histidine followed by the same treatment asE. coli except that R+ transconjugants were selected on AGGa agar containing KNO3 (0.4%), L-tryptophan, L-histidine, and tetracycline (75 ,ug/ml).
MIC. The minimal inhibitory concentration (MIC) was determined by the twofold agar dilution method (14) .
Inhibition of R plasmid transfer. The procedure of mating was the same as that described for the kinetics experiment except that an appropriate amount of a compound was added to the conjugation mixture. Samples were taken 20 min after mating in E. coli and Shigella flexneri and 50 min after mating in P. aeruginosa, followed by treatment with the blender. The colonies of donors, recipients, and R+ transconjugants were counted on appropriate agars (ALGa, AGGa, and AMGa agars forE. coli, SS agar for S. flexneri, and AGGa agar for P. aeruginosa) with or without required nutrients and a selective agent. Chloramphenicol (25 ,ug/ml) was used as a selective agent for bacteria carrying R,oo ,, R1i,,, Rio, R387, and S-a, and tetracycline (25 ,ug/ml for E. coli and 75 gg/ml for P. aeruginosa) was used for bacteria carrying one of the other R plasmids. The transfer rate was calculated according to the formula: transfer rate = 100 x (number of R+ transconjugants of a test group/number of R+ transconjugants of a control).
Pipemidic acid treatment before and during mating. Donor (W3630 R1oo1+) and recipient (W4354) cells ofE. coli grown exponentially in nutrient broth were harvested on membrane filters (Millipore
Corp.), resuspended in 1/10 volume of the same broth (about 7 x 109 cells/ml), and divided into two aliquots each; one received pipemidic acid (3.13 ,ug/ ml), and the other received distilled water. After incubation at 37°C for 30 min under static conditions, one of the donor cultures and one of the recipient cultures were mixed for mating and incubated for 20 min in the presence or absence of pipemidic acid. Mating mixtures consisted of 0.1 ml of a donor culture, 0.8 ml of a recipient culture, 0.1 ml of a pipemidic acid solution (313 ,ug/ml) or distilled water, and 9 ml of nutrient broth. Other procedures were as described above.
RESULTS
Kinetics of R plasmid transfer. The time course of R plasmid transfer was investigated in three mating systems. The number of R+ transconjugants increased exponentially until about 20 min after mixing of donor and recipient cells in the mating systems of E. coli, and until about 50 min in the mating system of P. aeruginosa (Fig. 2) . Sensitivity to the blender treatment disappeared about 20 min (or 50 min) after mixing in both systems. This result indicates that the transfer of the R plasmids was completed in both mating systems 20 min (or 50 min) after mixing.
Inhibition of R plasmid transfer by pipemidic acid-related compounds. The effect of pipemidic acid-related compounds on R plasmid transfer was examined by using two mating systems (Fig. 3) . In the mating ofE. coli W4861 6 .25 and 50; AT-1093,12.5 and 50; PA, 12.5 and 50; AT-988, 12.5 and 12.5; AT-88, 25 and 50; AT-1232, 100 and 100; AT-82, >100 and >100.
System B: Donor, P. aeruginosa M243 RP4+; recipient, P. aeruginosa ML4600. MICs (Mg/ml) for the donor and recipient: PPA, 12.5 and 12.5; NA, 100 and 100; PA, 400 and 400; HPA, 200 and 200. See Fig. 1 for compound abbreviations. donor was resistant to pipemidic acid and less markedly so when the recipient was resistant to it (Fig. 4) . Influence of bacterial strains used as donor or recipient on the transfer inhibition. Transfer inhibition was observed when bacterial strains used as donor or recipient were changed. Pipemidic, piromidic, hydroxypiromidic, and nalidixic acids inhibited the transfer of R,00o at their MIC values against donor cells in four mating systems, using donor strains sensitive to the acids (Table 4) . Fluctuation in the degree of inhibition between the four systems could not be ascribed to differences in drug sensitivity of the donors, because the MICs of the compounds against the four donors were the same except for piromidic acid.
Influence of R plasmids on transfer inhibition. Using eleven R plasmids in E. coli W4861 and four R plasmids in P. aeruginosa M243, we tested the transfer inhibition of these R plasmids by pipemidic, piromidic, hydroxypiromidic, and nalidixic acids. Transfer of the R plasmids was inhibited by these acids at their MIC values against the donors, although the degree of inhibition varied depending on the plasnids used - (Table 5 ). This variance was not due to differences in the MIC values of the compounds toward the donors carrying the R plasmids.
Influence of the time of drug treatment on transfer inhibition. Donor (W3630 R100,+) and recipient (W4354) cells of E. coli were treated with pipemidic acid before and during mating ( Table 6 ). The transfer rate was markedly decreased when pipemidic acid was present during mating (groups B, D, F, and H), whereas its inhibition was lower when the compound was absent during that period (groups A, C, E, and G). Pretreatment of the donor and recipient with pipemidic acid, followed by removal of the compound during mating (groups C, E, and G), caused only a small inhibitory effect on the transfer rate. This result suggests that the inhibition ofR plasmid transfer by pipemidic acid is not due to irreversible damage ofeither donor or recipient, but rather to the interruption of the mating process itself.
DISCUSSION
The present study demonstrated that pipemidic acid-related compounds inhibited the conjugal transfer ofR plasmids. Such inhibition was inversely correlated with the antibacterial activity of the compounds against donor cells.. However, there is no relationship between their bactericidal activity and the inhibition of R plasmid transfer, because none of the donors, recipients, or R+ transconjugants were killed during mating under the experimental conditions used. The inhibition was observed in mating systems of a number of bacterial strains carrying various R plasmids. Sensitivity of donors to the compound test and the presence of the compound during mating determined the degree of inhibition of R plasmid transfer. These results appear to be related to those of the pipemidic acid-related compound nalidixic acid, which inhibits the conjugal transfer of F'lac only when the donor is sensitive to the drug (1) , with the inhibitory effect of the drug lost by dilution of the mating mixture with drug-free medium (5) . Pipemidic acid-related compounds inhibit bacterial deoxyribonucleic acid (DNA) synthesis (4, 11, 12 Curtiss (3) demonstrated that nalidixic acid inhibited conjugal DNA replication of R64-11. It is likely that there is a common mechanism for the inhibition of R plasmid transfer via the inhibition of plasmid DNA synthesis by this group of compounds.
It is important from a practical viewpoint that these compounds can exert their action in vivo in humans. The toxicity of pipemidic acidrelated compounds is rather low, and some of them, i.e., pipemidic, piromidic, nalidixic, and oxolinic acids, have been applied to human diseases. Roe and Jones (13) found that carbenicillin was ineffective against a mixed infection with a carbenicillin-resistant, avirulent strain ofKlebsiella aerogenes and a carbenicillin-sensitive, virulent strain of P. aeruginosa in burned mice because of the emergence of carbenicillin-resistantP. aeruginosa by the transfer of an R plasmid determining carbenicillin resistance. The combined use of nalidixic acid and carbenicillin was effective due to the inhibition of R plasmid transfer by nalidixic acid. This result suggests that the other members of this group of compounds might also be effective in inhibiting in vivo transfer of R plasmids, for some of them are known to be more effective on bacterial infections in vivo than is nalidixic acid (6, 15) . ACKNOWLEDGMENT We are indebted to H. Hattori for his collaboration in a part of this study.
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